Philip Levin

1.9k total citations
48 papers, 770 citations indexed

About

Philip Levin is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Philip Levin has authored 48 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Philip Levin's work include Diabetes Management and Research (23 papers), Diabetes Treatment and Management (19 papers) and Metabolism, Diabetes, and Cancer (7 papers). Philip Levin is often cited by papers focused on Diabetes Management and Research (23 papers), Diabetes Treatment and Management (19 papers) and Metabolism, Diabetes, and Cancer (7 papers). Philip Levin collaborates with scholars based in United States, Russia and Mexico. Philip Levin's co-authors include James A. Joseph, George S. Roth, Wenhui Wei, Donald K. Ingram, Hiep Nguyen, Eric Wittbrodt, William B. Malarkey, Steve Zhou, Seoyoung C. Kim and Lee Bromberger and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Philip Levin

39 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Levin United States 16 415 166 136 106 74 48 770
Johanna L. Hannan United States 20 456 1.1× 174 1.0× 153 1.1× 122 1.2× 96 1.3× 71 1.1k
Chiara Mele Italy 20 364 0.9× 165 1.0× 152 1.1× 115 1.1× 26 0.4× 58 1.0k
Ellie M. Wekking Netherlands 15 468 1.1× 68 0.4× 47 0.3× 29 0.3× 57 0.8× 24 1.1k
K Vondra Czechia 21 567 1.4× 240 1.4× 289 2.1× 103 1.0× 50 0.7× 106 1.5k
Nils‐Olov Lunell Sweden 26 189 0.5× 109 0.7× 248 1.8× 126 1.2× 18 0.2× 91 1.7k
Vittorio Bocola Italy 9 186 0.4× 159 1.0× 138 1.0× 131 1.2× 33 0.4× 13 1000
Lilia Dakovska Bulgaria 15 321 0.8× 117 0.7× 232 1.7× 89 0.8× 35 0.5× 49 917
Brunella Licchelli Italy 18 412 1.0× 177 1.1× 62 0.5× 115 1.1× 11 0.1× 39 780
Luciana Aparecida Campos Brazil 18 208 0.5× 131 0.8× 140 1.0× 102 1.0× 69 0.9× 55 937
F E Kaiser United States 14 719 1.7× 342 2.1× 261 1.9× 79 0.7× 41 0.6× 22 1.2k

Countries citing papers authored by Philip Levin

Since Specialization
Citations

This map shows the geographic impact of Philip Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Levin more than expected).

Fields of papers citing papers by Philip Levin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Levin. The network helps show where Philip Levin may publish in the future.

Co-authorship network of co-authors of Philip Levin

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Levin. A scholar is included among the top collaborators of Philip Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Levin. Philip Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
5.
Levin, Philip, et al.. (2022). FACTOR XII DEFICIENCY IN CHILDREN: COAGULOPATHY OR LABORATORY FINDING. PEDIATRIA Journal named after G N SPERANSKY. 101(2). 50–55.
6.
Olshanskaya, Yulia, et al.. (2021). Essential thrombocythemia in children and adolescents — analysis of 31 cases. 66(4). 480–498.
7.
Levin, Philip, Byron J. Hoogwerf, Janet K. Snell‐Bergeon, et al.. (2020). Ultra Rapid-Acting Inhaled Insulin Improves Glucose Control in Patients With Type 2 Diabetes Mellitus. Endocrine Practice. 27(5). 449–454. 15 indexed citations
8.
Blonde, Lawrence, et al.. (2019). Real-world evidence in diabetes: relevance to clinical practice.. PubMed. 68(3 Suppl). 7 indexed citations
9.
Robbins, David C., et al.. (2019). 122-LB: iSage: Successful Basal Insulin Titration Managed by a Prescription-Only Digital Therapy for T2DM. Diabetes. 68(Supplement_1). 5 indexed citations
10.
Levin, Philip, Hiep Nguyen, Eric Wittbrodt, & Seoyoung C. Kim. (2017). Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research. Diabetes Metabolic Syndrome and Obesity. Volume 10. 123–139. 69 indexed citations
11.
12.
Levin, Philip, Wenhui Wei, Aleksandra Vlajnic, et al.. (2014). Initiating Injectable Therapy in US Managed Care Patients With Diabetes. The American Journal of Managed Care. 6. 1 indexed citations
13.
Levin, Philip, Wenhui Wei, Steve Zhou, Lin Xie, & Onur Başer. (2014). Outcomes and Treatment Patterns of Adding a Third Agent to 2 OADs in Patients with Type 2 Diabetes. Journal of Managed Care Pharmacy. 20(5). 501–512. 31 indexed citations
14.
Levin, Philip, et al.. (2012). Combination therapy with insulin glargine and exenatide: real-world outcomes in patients with type 2 diabetes. Current Medical Research and Opinion. 28(3). 439–446. 24 indexed citations
15.
Levin, Philip, James H. Mersey, Steven Zhou, & Lee Bromberger. (2011). Clinical Outcomes Using Long-Term Combination Therapy with Insulin Glargine and Exenatide in Patients with Type 2 Diabetes Mellitus. Endocrine Practice. 18(1). 17–25. 33 indexed citations
16.
17.
Levin, Philip. (2008). The cost‐effectiveness of insulin glargine vs. neutral protamine Hagedorn insulin in type 2 diabetes: a focus on health economics. Diabetes Obesity and Metabolism. 10(s2). 66–75. 9 indexed citations
18.
Kolt, Gregory S., et al.. (2000). Injury Toll Following the 1997 Maccabiah Games Bridge Collapse. Sports Medicine. 30(1). 63–71. 2 indexed citations
19.
Levin, Philip, et al.. (1990). ACTH1-24Stimulates Muscle Cell Glucose Uptake. Hormone and Metabolic Research. 22(12). 608–611. 3 indexed citations
20.
Levin, Philip, et al.. (1987). Linogliride fumarate, representing a new class of oral hypoglycemic agent for diabetes. Clinical Pharmacology & Therapeutics. 42(5). 498–503. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johanna L. Hannan Breakdown of academic impact, for papers by Chiara Mele Breakdown of academic impact, for papers by Ellie M. Wekking Breakdown of academic impact, for papers by K Vondra Breakdown of academic impact, for papers by Nils‐Olov Lunell Breakdown of academic impact, for papers by Vittorio Bocola Breakdown of academic impact, for papers by Lilia Dakovska Breakdown of academic impact, for papers by Brunella Licchelli Breakdown of academic impact, for papers by Luciana Aparecida Campos Breakdown of academic impact, for papers by F E Kaiser
Rankless by CCL
2026